IGC Pharma raises ~$234k in registered direct offering of 780k shares at $0.30/share

IGC Pharma, Inc.

Issued 779,997 shares of common stock at $0.30 per share for gross proceeds of ~$234k.
Offering closed on or about January 5, 2026 under existing shelf registration statement.
Net proceeds to fund working capital, clinical development, R&D, and other business initiatives.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IGC Pharma, Inc. entered into 2025 Subscription Agreement with certain investors valued at approximately $234 thousand (effective 2026-01-05).

Action: entry
Agreement: equity purchase
Counterparty: certain investors
Value: approximately $234 thousand
Effective: 2026-01-05

Exact text from the filing

entered into a Subscription Agreement (the “2025 Subscription Agreement”) with certain investors named therein (collectively, the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors, in a registered direct offering (the “Offering”), an aggregate of 779,997 shares of the Company’s common stock

View on SEC.gov

Browse all material agreements →

IGC Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-26-000032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.